Tianxia Lan

2.5k total citations · 4 hit papers
23 papers, 1.5k citations indexed

About

Tianxia Lan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Tianxia Lan has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Tianxia Lan's work include Immunotherapy and Immune Responses (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Immune cells in cancer (4 papers). Tianxia Lan is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Immune cells in cancer (4 papers). Tianxia Lan collaborates with scholars based in China, United States and Macao. Tianxia Lan's co-authors include Xiawei Wei, Min Luo, Xiawei Wei, Yuquan Wei, Minyang Fu, Ting Luo, Yuan Hu, Kun‐Liang Guan, Li Chen and Zhen Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Tianxia Lan

23 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Hippo signalling pathway and its implications in human health and diseases

2022 358 citations Minyang Fu, Yuan Hu et al. Signal Transduction and Targeted Therapy profile →
Mesenchymal stem/stromal cells in cancer therapy

2021 225 citations Tianxia Lan, Min Luo et al. Journal of Hematology & Oncology profile →
CCL5/CCR5 axis in human diseases and related treatments

2021 201 citations Zhen Zeng, Tianxia Lan et al. Genes & Diseases profile →
Tumor-associated neutrophils and neutrophil-targeted cancer therapies

2022 187 citations Haiying Que, Tianxia Lan et al. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tianxia Lan China	15	643	461	391	211	185	23	1.5k
Alba De Martino Spain	20	857 1.3×	273 0.6×	220 0.6×	148 0.7×	186 1.0×	35	1.8k
Panagiotis Karagiannis United Kingdom	19	486 0.8×	558 1.2×	420 1.1×	152 0.7×	102 0.6×	42	1.5k
Praveen Bhoopathi United States	27	964 1.5×	403 0.9×	628 1.6×	204 1.0×	500 2.7×	52	1.9k
Christophe Cataisson United States	23	1.0k 1.6×	515 1.1×	424 1.1×	141 0.7×	304 1.6×	44	1.9k
Giorgio Mangino Italy	26	795 1.2×	559 1.2×	318 0.8×	61 0.3×	283 1.5×	66	1.7k
Ralph Francescone United States	15	983 1.5×	383 0.8×	493 1.3×	97 0.5×	284 1.5×	23	1.5k
Tetyana Yevsa Germany	14	860 1.3×	696 1.5×	580 1.5×	107 0.5×	390 2.1×	25	2.0k
Xia Zhang China	22	667 1.0×	704 1.5×	434 1.1×	67 0.3×	249 1.3×	59	1.8k

Countries citing papers authored by Tianxia Lan

Since Specialization

Citations

This map shows the geographic impact of Tianxia Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxia Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxia Lan more than expected).

Fields of papers citing papers by Tianxia Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxia Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxia Lan. The network helps show where Tianxia Lan may publish in the future.

Co-authorship network of co-authors of Tianxia Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxia Lan. A scholar is included among the top collaborators of Tianxia Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxia Lan. Tianxia Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wan, Dandan, Liang Yu, Li Chen, et al.. (2024). Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes. Acta Pharmaceutica Sinica B. 14(10). 4577–4590. 4 indexed citations

Luo, Jingwen, Fei Mo, Zhe Zhang, et al.. (2024). Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform. Cellular and Molecular Immunology. 21(11). 1251–1265. 4 indexed citations

Tang, Fan, Yan Tie, Tianxia Lan, et al.. (2023). Surgical Treatment of Osteosarcoma Induced Distant Pre‐Metastatic Niche in Lung to Facilitate the Colonization of Circulating Tumor Cells. Advanced Science. 10(28). e2207518–e2207518. 21 indexed citations

Lu, Tianqi, Ziqi Zhang, Zhenfei Bi, et al.. (2023). TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway. Journal for ImmunoTherapy of Cancer. 11(3). e005430–e005430. 35 indexed citations

Wang, Jiayu, Tianxia Lan, Yuquan Wei, & Yoshimasa Tanaka. (2023). Omicron variant: a booster depending on infection histories. Signal Transduction and Targeted Therapy. 8(1). 6–6. 2 indexed citations

Hong, Lei, Aqu Alu, H. J. Yang, et al.. (2022). Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants. Signal Transduction and Targeted Therapy. 7(1). 159–159. 31 indexed citations

Lan, Tianxia, Ting Liu, Bin Shao, et al.. (2022). CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis. The Journal of Immunology. 208(10). 2425–2435. 22 indexed citations

Lan, Tianxia, Haiying Que, Min Luo, Xia Zhao, & Xiawei Wei. (2022). Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy. Molecular Cancer. 21(1). 71–71. 20 indexed citations

Que, Haiying, et al.. (2022). Tumor-associated neutrophils and neutrophil-targeted cancer therapies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(5). 188762–188762. 187 indexed citations breakdown →

10.

Fu, Minyang, Dandan Peng, Tianxia Lan, Yuquan Wei, & Xiawei Wei. (2022). Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases. Acta Pharmaceutica Sinica B. 12(4). 1740–1760. 57 indexed citations

11.

Fu, Minyang, Yuan Hu, Tianxia Lan, et al.. (2022). The Hippo signalling pathway and its implications in human health and diseases. Signal Transduction and Targeted Therapy. 7(1). 376–376. 358 indexed citations breakdown →

12.

Que, Haiying, Weiqi Hong, Tianxia Lan, et al.. (2022). Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal Transduction and Targeted Therapy. 7(1). 399–399. 22 indexed citations

13.

Song, Yanlin, Yuan Cheng, Tianxia Lan, et al.. (2022). ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma. Cancer Letters. 554. 216012–216012. 5 indexed citations

14.

Ao, Danyi, Tianxia Lan, Xuemei He, et al.. (2022). SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development. SHILAP Revista de lepidopterología. 3(1). e126–e126. 78 indexed citations

15.

Liu, Xiang, Tianxia Lan, Fei Mo, et al.. (2021). Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma. Frontiers in Cell and Developmental Biology. 9. 689613–689613. 14 indexed citations

16.

Nie, Wen, Tianxia Lan, Yuan Xia, et al.. (2021). Crystalline silica induces macrophage necrosis and causes subsequent acute pulmonary neutrophilic inflammation. Cell Biology and Toxicology. 38(4). 591–609. 8 indexed citations

17.

Zeng, Zhen, Tianxia Lan, Yuquan Wei, & Xiawei Wei. (2021). CCL5/CCR5 axis in human diseases and related treatments. Genes & Diseases. 9(1). 12–27. 201 indexed citations breakdown →

18.

Lan, Tianxia, Min Luo, & Xiawei Wei. (2021). Mesenchymal stem/stromal cells in cancer therapy. Journal of Hematology & Oncology. 14(1). 195–195. 225 indexed citations breakdown →

19.

Lan, Tianxia & Xiawei Wei. (2021). Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles?. Molecular Biomedicine. 2(1). 14–14. 3 indexed citations

20.

Wan, Dandan, Haiying Que, Li Chen, et al.. (2021). Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response. Nano Letters. 21(19). 7960–7969. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact